https://www.cochrane.org/th/evidence/CD002849_do-pharmacotherapies-which-reduce-anxiety-help-smokers-quit
Do pharmacotherapies which reduce anxiety help smokers to quit | Cochrane
reduce anxietypharmacotherapieshelpsmokersquit
https://pmc.ncbi.nlm.nih.gov/articles/PMC10870088/
Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms - PMC
An average of 60-80% of all menopausal women experience bothersome vasomotor symptoms (VMSs), such as flushing and sweating, within the first seven years of...
for thevasomotor symptomspharmacotherapiestreatmentpostmenopausal
https://www.rti.org/publication/design-development-pharmacotherapies-substance-abuse-2006-nathan-b-eddy-memorial-award-lecture
Design and Development of Pharmacotherapies for Substance Abuse | RTI
design and developmentsubstance abusepharmacotherapiesrti
https://www.rti.org/publication/pharmacotherapies-treatment-cocaine-abuse-preclinical-aspects
Pharmacotherapies for treatment of cocaine abuse | RTI
Drug abuse, addiction, and dependence represent a major and increasing threat to public health. The 1997 National Household Survey on Drug Abuse (NHSDA)...
cocaine abusepharmacotherapiestreatmentrti
https://www.abebooks.com/9780781791229/ASAM-Patient-Placement-Criteria-Supplement-0781791227/plp
ASAM Patient Placement Criteria: Supplement on Pharmacotherapies for Alcohol Use Disorders:...
ASAM Patient Placement Criteria: Supplement on Pharmacotherapies for Alcohol Use Disorders provides a framework for placing patients with alcohol use...
alcohol useasampatientplacementcriteria